Klinički efekti hemofereze kod hemoblastoza, inhibitor he- mofilije i miastenije gravis. Acta Medica Academica, [S. l.], v. 22, p. 177–189, 2026. DOI: 10.5644/Radovi.242. Disponível em: https://www.ama.ba/index.php/ama/article/view/953. Acesso em: 29 may. 2026.